ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 85 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $8,624,000 | -54.3% | 2,024,400 | -43.0% | 0.15% | -54.0% |
| Q1 2021 | $18,851,000 | -1.5% | 3,550,000 | 0.0% | 0.33% | -1.2% |
| Q4 2020 | $19,135,000 | -78.2% | 3,550,000 | -67.7% | 0.33% | -73.5% |
| Q3 2020 | $87,780,000 | -12.4% | 11,000,000 | +7.8% | 1.25% | -37.0% |
| Q2 2020 | $100,170,000 | +2871.5% | 10,200,000 | +5446.5% | 1.98% | +113.4% |
| Q2 2015 | $3,371,000 | – | 183,900 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |